Genetic polymorphisms of CYP2E1 and GSTP1 in a south indian population - comparison with north indians, caucasians and chinese

Asian Pacific Journal of Cancer Prevention

Volumn 6, Issue 3, 2005, Pages 315-319

  Soya, S S ^a   Padmaja, N ^a   Adithan, C ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

CYP2E1; Genotyping; GSTP1; Indian; Polymorphism; Tamilian

Indexed keywords

CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN;

ADULT; ARTICLE; CAUCASIAN; CHINA; COMPARATIVE STUDY; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; INDIA; MALE; MIDDLE AGED; NEOPLASM; NUCLEOTIDE SEQUENCE;

ADULT; CHINA; CYTOCHROME P-450 CYP2E1; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 32944460444     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Adithan C, Gerard N, Vasu S, et al (2003a). Allele and genotype frequency of CYP2C19 in a Tamilian population. Br J Clin Pharmacol, 56, 331-3.
2. Adithan C, Gerard N, Naveen AT, et al (2003b). Genotype and allele frequency of CYP2D6 in Tamilian population. Eur J Clin Pharmacol, 59, 517-20.
3. Albano E, Clot P, Morimoto M, et al (1996). Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology, 23, 155-63.
4. Carriere V, Berthou F, Baird S, et al (1996). Human Cytochrome P450 (CYP2E1): from genotype to phenotype. Pharmacogenetics, 6, 203-11.
5. Caro AA, Cederbaum AI (2004). Oxidative stress, toxicology and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol, 44, 27-42.
6. Correia MA (2004). Drug Biotransformation. In Basic and Clinical Pharmacology. (ed Katzung BG); The Mc Graw Hill Companies; Newyork, pp. 56.
7. Garte S, Gaspari L, Alexandrie A, et al (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 10, 1239-48.
8. Gonzalez MV, Alvarez V, Pello MF, et al (1998). Genetic polymorphism of N-acetyltransferase-2, glutathione Stransferse- M1 and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol, 51, 294-8.
9. Hildesheim A, Anderson LM, Chen CJ, et al (1997). CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst, 89, 1207-12.
10. Haufroid V, Buchet J, Gardinal S, Lison D (2002). Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene. Int Arch Ocup Environ Health, 75, 453-8.
11. Haufroid V, Jakubowski M, Janasik B, et al (2002). Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. Pharmacogenetics, 12, 691-702.
12. Haufroid V, Buchet J, Gardinal S, et al (2001). Importance of genetic polymorphisms of drug metabolizing enzymes for the interpretation of biomarkers of exposure to styrene. Biomarkers, 6, 236-49.
13. Hayashi S, Watanabe J, Kawajiri K (1991). Genetic polymorphism in the 5'- flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochemistry, 110, 559-65.
14. Hayes JD, Flanagan JU, Jowsey IR (2005). Glutathione Transferases. Annu Rev Pharmacol Toxicol, 45, 51-88.
15. Hung HC, Chuang J, Chien YC, et al (1997). Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev, 6, 901-5.
16. Kehrer JP (1993). Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol, 23, 21-48.
17. Kote-Jarai Z, Easton D, Edwards SM, et al (2001). Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics, 11, 325-30.
18. Marsh S, McLeod HL (2004). Cancer pharmacogenetics. Br J Cancer, 90, 8-11.
19. Matthias C, Bockmuhl U, Jahnke V, et al (1998). Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics, 8, 91-100.
20. Mishra DK, Kumar A, Srivastava DSL, Mittal RD (2004). Allelic variations of GSTT1, GSTM1 and GSTP1 genes in a North Indian population. Asian Pac J Cancer Prev, 5, 362-5.
21. Mittal RD, Srivastava DS, Mandhani A, Mittal B (2005). Genetic Polymorphism of Drug Metabolizing Enzymes (CYP2E1, GSTP1) and Susceptibility to Bladder Cancer in North India. Asian Pac J Cancer Prev, 6, 6-9.
22. Naveen AT, Adithan C, Padmaja N, et al (2004). Glutathione S transferase M1 and T1 null genotype distribution in south Indians. Eur J Clin Pharmacol, 60, 403-6.
23. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004). Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem, 266, 1-9.
24. Tan W, Song N, Wang G, et al (2000). Impact of Genetic Polymorphisms in Cytochrome P450 2E1 and Glutathione STransferases M1, T1, and P1 on Susceptibility to Esophageal Cancer among High-Risk Individuals in China. Cancer Epidemiol Biomarkers Prev, 9, 551-6.
25. Tanaka E, Terada M, Misawa S (2000). Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther, 2, 165-75.
26. Townsend DM, Tew KD (2003). Cancer Drugs, Genetic Variation and the Glutathione-S-Transferase Gene Family. Am J Pharmacogenomics, 3, 157-72.
27. Uematsu F, Kikuchi H, Motomiya M, et al (1991). Association between restriction fragment polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res, 82, 254-6.
28. Villeneuve JP, Pichette V (2004). Cytochrome P450 and liver diseases. Curr Drug Metab, 5, 273-82.
29. Watanabe J, Hayashi S, Nakachi K, et al (1990). PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucl. Acids Res, 18, 7194.
30. Wong NACS, Rae F, Simpson KJ, Murray GD, Harrison DJ (2000). Genetic polymorphism of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. J Clin Pathol: Mol Pathol, 53, 88- 93.
31. Xu Q , Lin G, Chen W, Zhou X, Lin L (2002). Relation between the expression of P-gp and GST-pi in oral and maxillofacial squamous carcinoma and chemoresistance. Zhonghua Kou Qiang Yi Xue Za Zhi, 37, 90-3.
32. Yu M, Gladek-Yarborough A, Chiamprasert S, et al (1995). Cytochrome P450 2E1 and Glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-75.